Hot Flashes

Estrigenix Therapeutics, Inc. presents new hormone replacement therapy research at the 10th Drug Discovery Strategic Summit

MILWAUKEE (Oct. 25, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is presenting at the 10th Drug Discovery Strategic Summit on Thursday, October 27, and Friday, October 28 at the Grand Hyatt at San Francisco airport, located at 55 South McDonnell Road in San Francisco.  Estrigenix’s chief executive Estrigenix Therapeutics, Inc. presents new hormone replacement therapy research at the 10th Drug Discovery Strategic Summit

Estrigenix Therapeutics, Inc. presents at Women’s Health Innovation Summit 2022 in Boston

MILWAUKEE (OCT 5, 2022) – Estrigenix Therapeutics, Inc., a Wisconsin-based, privately held pharmaceutical company leading the way in estrogen biology, is proud to have been a presenter at the Women’s Health Innovation Summit 2022 in Boston. William Donaldson, Ph.D., chief executive officer (CEO) of Estrigenix presented an abstract entitled, “Discovery of Selective ER Beta Agonists Estrigenix Therapeutics, Inc. presents at Women’s Health Innovation Summit 2022 in Boston